Preeclampsia grave en primigesta de 33 años con embarazo gemelar de 34 semanas

The objective of this clinical case was to identify the risk factors that most occur in women with a diagnosis of severe preeclampsia. It was developed from the information collected from the clinical history of a 33-year-old woman with a twin pregnancy of 34 years. weeks of gestation that I present a clinical picture of PRE ECLAMPSIA SEVERA; the purpose of this research work is to analyze the results of diagnosis and treatment, to establish whether the procedures that were applied based on the theory reviewed in bibliographies of scientific authors and clinical practice guides on the management of this pathology, fulfilled the expected prognosis both in the mother and in the product, according to the etiology of the disease. To analyze each of them to control and prevent this disease and thus avoid maternal mortality and perinatal morbidity and mortality should be noted that, according to studies For several decades, many researchers have invested efforts and resources in elucidating and knowing to their true limits a process that, although classic, has evolved from concept, name, identity and that, to date, has not been able to know all its origin. The hypertensive states of pregnancy (EHE) continue to be one of the most important unresolved obstetric problems. Despite the great research efforts that have been made and that goes back to the pre-Hippocratic era. An important aspect that we can analyze is that Gemiparity increases the risk of pre-eclampsia from before 20 weeks of gestation. Pre-eclampsia occurs more in nulliparous than in multiparous, without statistical significance. PE complicates chorionic cufflinks more than chorionic monkeys, leaving the corroboration of the significance. The results of recent research conclude that the treatment of maternal hypertension benefits the mother, and although the treatment could affect fetal growth, it does not increase fetal / neonatal morbidity or mortality. Using drugs such as nifedipine, hydralazine, labetalol, alfametildopa. With different administration guidelines

• Main Author: Batallas Beltran, Josselin Betzabeth (author)
• Format: bachelorThesis
• Language: spa
• Published: 2018
• Subjects: Pre eclampsia; Hipertensión; Morbimortalidad; Labetalol
• Online Access: http://dspace.utb.edu.ec/handle/49000/4519